Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Hemostasis Diagnostics Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in incidences of hemostasis disorders worlwide
5.1.1.2. Inclination toward point-of-care testing solutions
5.1.1.3. Growing awareness of hemostasis disorders and emphasis on early diagnosis
5.1.2. Restraints
5.1.2.1. High cost of diagnosis and incidences of product recall
5.1.3. Opportunities
5.1.3.1. Utilization of personalized medicine approach to deliver tailored treatments
5.1.3.2. Advancements in diagnostic methods for hemostasis
5.1.4. Challenges
5.1.4.1. Complex testing methods for hemostasis diagnosis
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Hemostasis Diagnostics Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Laboratory Analyzers
6.4. Point-of-Care Testing Systems

7. Hemostasis Diagnostics Market, by Test Type
7.1. Introduction
7.2. Activated Clotting Time
7.3. Activated Partial Thromboplastin Time
7.4. D Dimer Test
7.5. Fibrinogen Test
7.6. Platelet Aggregation Test
7.7. Prothrombin Time (PT) Test

8. Hemostasis Diagnostics Market, by End Use
8.1. Introduction
8.2. Home Care Setting
8.3. Hospitals/Clinics
8.4. Independent Diagnostic Laboratories

9. Americas Hemostasis Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Hemostasis Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Hemostasis Diagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. ARUP Laboratories
13.1.3. Becton, Dickinson and Company
13.1.4. Bio-Rad Laboratories, Inc.
13.1.5. bioM?rieux SA
13.1.6. Danaher Corporation
13.1.7. DiaPharma Group, Inc.
13.1.8. F. Hoffmann-La Roche Ltd.
13.1.9. Grifols, S.A.
13.1.10. Haemonetics Corporation
13.1.11. Helena Laboratories Corporation
13.1.12. HemoSonics, LLC
13.1.13. HORIBA Group
13.1.14. Laboratory Corporation of America Holdings
13.1.15. Medtronic PLC
13.1.16. Merck & Co., Inc.
13.1.17. Randox Laboratories Ltd.
13.1.18. Siemens AG
13.1.19. Stago Group
13.1.20. Sysmex America, Inc.
13.1.21. Sysmex Europe SE
13.1.22. Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH
13.1.23. Thermo Fisher Scientific Inc.
13.1.24. Werfen, S.A.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. HEMOSTASIS DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. HEMOSTASIS DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. HEMOSTASIS DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HEMOSTASIS DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2023 VS 2030 (%)
FIGURE 12. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HEMOSTASIS DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. HEMOSTASIS DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. HEMOSTASIS DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. HEMOSTASIS DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY LABORATORY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TESTING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 10. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ACTIVATED CLOTTING TIME, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D DIMER TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FIBRINOGEN TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PLATELET AGGREGATION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTHROMBIN TIME (PT) TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 17. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS/CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 30. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 47. CHINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CHINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 50. INDIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. INDIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 56. JAPAN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. JAPAN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 74. THAILAND HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. THAILAND HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. DENMARK HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 87. EGYPT HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. EGYPT HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 90. FINLAND HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. FINLAND HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 93. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 102. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 111. NORWAY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. NORWAY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 114. POLAND HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. POLAND HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 117. QATAR HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. QATAR HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 138. TURKEY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. TURKEY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 147. HEMOSTASIS DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 148. HEMOSTASIS DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 149. HEMOSTASIS DIAGNOSTICS MARKET LICENSE & PRICING